A clinical trial to study the effects of customized insoles with metatarsal transverse pads in patients with metatarsalgia during stair climbing

The effect of customized insoles with metatarsal transverse pads for the assessment of pain and performance ability in the patients with metatarsalgia during the stair climbing. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057980

Enrollment

Registered

2023-09-25

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M774- Metatarsalgia

Interventions

Intervention1: Customized Insoles with metatarsal transverse pads: The insole is customized or tailored to fit the unique shape and contours of the persons foot. It is typically made from a mold or im

Eligibility

Inclusion criteria

Inclusion criteria: 1)The patient reported to the institute for metatarsal region pain and forefoot discomfort. 2)Subjects with primary metatarsalgia and its related pathology. 3)Subjects having age in between 18 years to 60 years. 4)Subjects not using assistive device.

Exclusion criteria

Exclusion criteria: 1)Metabolic diseases which could cause problems in walking and/or secondary metatarsalgia; 2)Neurologic diseases which could possibly influence walking 3)Problems which could result in secondary foot problems, such as rheumatoid arthritis, diabetes mellitus, and circulatory problems;

Design outcomes

Primary

Measure	Time frame
AOFAS midfoot questionnaireTimepoint: Three weeks	—

Secondary

Measure	Time frame
Not ApplicableTimepoint: Not Applicable	—

Countries

India

Contacts

Public ContactMayank Rawat

Pandit Deendayal Upadhyaya National Institute for Persons with Physical Disabilities (Divyangjan)

mohitgupta201057@yahoo.com8826976966

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026